Languita, Jufith O.
HRN: 22-38-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/16/2024
09/29/2024
IV
2.25
IV
Hepatic Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes